News

Phase 1 results of a next-generation treatment targeting KRAS G12C, the cause of lung cancer, colon cancer, and pancreatic ...
researchers and participants throughout all phases of clinical research and is tailored to meet the regulatory requirements of more than 100 territories, ensuring smooth and compliant trial ...
SAN ANTONIO, May 1, 2025 /PRNewswire/ -- Summit Clinical Research, LLC ("Summit"), a leading ... of key senior leaders to drive the next phase of Summit's growth. Dr. Naim Alkhouri, MD, FAASLD ...